服务性筛查时代的晚期乳腺癌发生率:意大利40万女性队列研究
该队列纳入逾40万名于20世纪90年代首次受邀参加区域筛查项目的意大利女性,随访13年乳腺癌发病情况。结果显示,参加筛查者浸润性癌风险轻度升高(IRR=1.05),但II期及以上乳腺癌风险降低28%(IRR=0.72)。作者估计参加筛查与II期及以上乳腺癌减少近30%相关。
要点
- 参加筛查与T2及以上乳腺癌风险降低39%相关(IRR=0.61)。
- 参加筛查与淋巴结阳性乳腺癌风险降低19%相关(IRR=0.81)。
- 参加筛查与II期及以上乳腺癌风险降低28%相关(IRR=0.72)。
核心结论
- 比较参加者与非参加者的分期特异性乳腺癌发病率,作者估计参加筛查与II期及以上乳腺癌减少近30%相关。
- 数据提示自我选择偏倚有限,受邀女性相比筛查前时代晚期乳腺癌减少17%。
研究设计与样本
- 队列研究纳入逾40万名于20世纪90年代首次受邀参加区域筛查项目的意大利女性,随访乳腺癌发病13年。
- 获取个体筛查暴露数据并与总体及分期特异性乳腺癌发病率相关分析,使用社会经济状况和筛查前发病率数据评估自我选择偏倚。
主要发现
- 参加筛查与总体(原位及浸润性)乳腺癌风险升高10%相关(IRR=1.10;95%CI:1.06-1.14)。
- 仅浸润性癌时,参加筛查与风险升高5%相关(IRR=1.05;95%CI:1.01-1.09)。
- 参加者T2及以上乳腺癌风险降低39%(IRR=0.61;95%CI:0.57-0.66)。
- 参加者淋巴结阳性乳腺癌风险降低19%(IRR=0.81;95%CI:0.76-0.86)。
- 参加者II期及以上乳腺癌风险降低28%(IRR=0.72;95%CI:0.68-0.76)。
临床怎么用
- 原文未据此给出推荐。
- 作者结论指出参加筛查与II期及以上乳腺癌减少近30%相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The objective of this study was to evaluate if mammography screening attendance is associated with a reduction in late-stage breast cancer incidence. METHODS: The cohort included over 400,000 Italian women who were first invited to participate in regional screening programmes during the 1990s and were followed for breast cancer incidence for 13 years. We obtained individual data on their exposure to screening and correlated this with total and stage-specific breast cancer incidence. Socio-economic status and pre-screening incidence data were used to assess the presence of self-selection bias. RESULTS: Overall, screening attendance was associated with a 10% excess risk of in situ and invasive breast cancer (IRR = 1.10; 95% confidence interval (CI): 1.06-1.14), which dropped to 5% for invasive cancers only (IRR = 1.05; 95% CI: 1.01-1.09). There were significant reductions among attenders for specific cancer stages; we observed a 39% reduction for T2 or larger (IRR = 0.61; 95% CI: 0.57-0.66), 19% for node positives (IRR = 0.81; 95% CI: 0.76-0.86) and 28% for stage II and higher (IRR = 0.72; 95% CI: 0.68-0.76). Our data suggest that the presence of self-selection bias is limited and, overall, invited women experienced a 17% reduction of advanced cancers compared with pre-screening rates. CONCLUSIONS: Comparing attenders' and non-attenders' stage-specific breast cancer incidence, we have estimated that screening attendance is associated with a reduction of nearly 30% for stages II+.
引用
- Puliti D, Bucchi L, Mancini S, et al. Advanced breast cancer rates in the epoch of service screening: The 400,000 women cohort study from Italy. Eur J Cancer. 2017. PMID: 28222306. doi:10.1016/j.ejca.2016.12.030
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。